Proadipogenic effects of lactoferrin in human subcutaneous and visceral preadipocytes

Journal of Nutritional Biochemistry

Volumn 22, Issue 12, 2011, Pages 1143-1149

  Moreno Navarrete, José María ^a   Ortega, Francisco ^a   Sabater, Mònica ^a   Ricart, Wifredo ^a   Fernández Real, José Manuel ^a  

^a Instituto de Salud Carlos III   (Spain)

Author keywords

Adipogenesis and insulin action; Lactoferrin

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; BIOLOGICAL MARKER; FATTY ACID BINDING PROTEIN 4; FATTY ACID SYNTHASE; INSULIN; INTERLEUKIN 6; INTERLEUKIN 8; LACTOFERRIN; MEMBRANE PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE B; RETINOBLASTOMA BINDING PROTEIN 1; SIX TRANSMEMBRANE PROTEIN OF PROSTATE 2; UNCLASSIFIED DRUG;

ADIPOGENESIS; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; INHIBITION KINETICS; INSULIN METABOLISM; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; PROADIPOCYTE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SUBCUTANEOUS FAT; WESTERN BLOTTING;

ADIPOCYTES; ADIPOGENESIS; AMP-ACTIVATED PROTEIN KINASES; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; GENES, REGULATOR; HUMANS; INFLAMMATION; LACTOFERRIN; PHOSPHORYLATION; PPAR GAMMA; RETINOBLASTOMA PROTEIN;

EID: 80655145285     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.09.015     Document Type: Article

References (38)

1. Lefterova M.I., Zhang Y., Steger D.J., Schupp M., Schug J., Cristancho A., et al. PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev 2008, 22:2941-2952.
2. Lefterova M.I., Lazar M.A. New developments in adipogenesis. Trends Endocrinol Metab 2009, 20:107-114.
3. Lumeng C.N., Deyoung S.M., Saltiel A.R. Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins. Am J Physiol Endocrinol Metab 2007, 292:E166-E174.
4. Constant V.A., Gagnon A., Landry A., Sorisky A. Macrophage conditioned medium inhibits the differentiation of 3T3-L1 and human abdominal preadipocytes. Diabetologia 2006, 49:1402-1411.
5. Ward P.P., Paz E., Conneely O.M. Multifunctional roles of lactoferrin: a critical overview. Cell Mol Life Sci 2005, 62:2540-2548.
6. Otsuki K., Yakuwa K., Sawada M., Hasegawa A., Sasaki Y., Mitsukawa K., et al. Recombinant human lactoferrin has preventive effects on lipopolysaccharide-induced preterm delivery and production of inflammatory cytokines in mice. J Perinat Med 2005, 33:320-323.
7. Conneely O.M. Antiinflammatory activities of lactoferrin. J Am Coll Nutr 2001, 20:389S-395S. [discussion 396S-7S].
8. Hayashida K., Kaneko T., Takeuchi T., Shimizu H., Ando K., Harada E. Oral administration of lactoferrin inhibits inflammation and nociception in rat adjuvant-induced arthritis. J Vet Med Sci 2004, 66:149-154.
9. Kruzel M.L., Harari Y., Chen C.Y., Castro G.A. The gut. A key metabolic organ protected by relationship to reduced serum TNF alpha level and increased turnover of neutrophils. Inflamm Res 2004, 53:92-96.
10. Haversen L., Ohlsson B.G., Hahn-Zoric M., Hanson L.A., Mattsby-Baltzer I Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-kappa B. Cell Immunol 2002, 220:83-95.
11. Zhou Y., Zeng Z., Zhang W., Xiong W., Wu M., Tan Y., et al. Lactotransferrin: a candidate tumor suppressor-deficient expression in human nasopharyngeal carcinoma and inhibition of NPC cell proliferation by modulating the mitogen-activated protein kinase pathway. Int J Cancer 2008, 123:2065-2072.
12. Letchoumy P.V., Mohan K.V., Stegeman J.J., Gelboin H.V., Hara Y., Nagini S. In vitro antioxidative potential of lactoferrin and black tea polyphenols and protective effects in vivo on carcinogen activation, DNA damage, proliferation, invasion, and angiogenesis during experimental oral carcinogenesis. Oncol Res 2008, 17:193-203.
13. Naot D., Grey A., Reid I.R., Cornish J. Lactoferrin a novel bone growth factor. Clin Med Res 2005, 3:93-101.
14. p473SerAKT while impairing adipocyte differentiation. Int J Obes (Lond) 2009, 33:991-1000.
15. Moreno-Navarrete J.M., Ortega F.J., Bassols J., Ricart W., Fernandez-Real J.M. Decreased circulating lactoferrin in insulin resistance and altered glucose tolerance as a possible marker of neutrophil dysfunction in type 2 diabetes. J Clin Endocrinol Metab 2009, 94:4036-4044.
16. Tamano S., Sekine K., Takase M., Yamauchi K., Iigo M., Tsuda H. Lack of chronic oral toxicity of chemopreventive bovine lactoferrin in F344/DuCrj rats. Asian Pac J Cancer Prev 2008, 9:313-316.
17. Takeuchi T., Shimizu H., Ando K., Harada E. Bovine lactoferrin reduces plasma triacylglycerol and NEFA accompanied by decreased hepatic cholesterol and triacylglycerol contents in rodents. Br J Nutr 2004, 91:533-538.
18. Mir R., Kumar R.P., Singh N., Vikram G.P., Sinha M., Bhushan A., et al. Specific interactions of C-terminal half (C-lobe) of lactoferrin protein with edible sugars: binding and structural studies with implications on diabetes. Int J Biol Macromol 2010, 47:50-59.
19. Pilvi T.K., Harala S., Korpela R., Mervaala E.M. Effects of high-calcium diets with different whey proteins on weight loss and weight regain in high-fat-fed C57BL/6J mice. Br J Nutr 2009, 102:337-341.
20. Ono T., Murakoshi M., Suzuki N., Iida N., Ohdera M., Iigo M., et al. Potent anti-obesity effect of enteric-coated lactoferrin: decrease in visceral fat accumulation in Japanese men and women with abdominal obesity after 8-week administration of enteric-coated lactoferrin tablets. Br J Nutr 2010, 9:1-8.
21. Knudsen E.S., Wang J.Y. Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites. J Biol Chem 1996, 271:8313-8320.
22. Cole K.A., Harmon A.W., Harp J.B., Patel Y.M. Rb regulates C/EBPbeta-DNA-binding activity during 3T3-L1 adipogenesis. Am J Physiol Cell Physiol 2004, 286:C349-354.
23. An Z., Wang H., Song P., Zhang M., Geng X., Zou M.H. Nicotine-induced activation of AMP-activated protein kinase inhibits fatty acid synthase in 3T3L1 adipocytes: a role for oxidant stress. J Biol Chem 2007, 282:26793-26801.
24. Ng Y., Ramm G., Burchfield J.G., Coster A.C., Stöckli J., James D.E. Cluster analysis of insulin action in adipocytes reveals a key role for Akt at the plasma membrane. J Biol Chem 2010, 285:2245-2257.
25. Peng X.D., Xu P.Z., Chen M.L., Hahn-Windgassen A., Skeen J., Jacobs J., et al. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev 2003, 17:1352-1365.
26. Baudry A., Yang Z.Z., Hemmings B.A. PKBalpha is required for adipose differentiation of mouse embryonic fibroblasts. J Cell Sci 2006, 119:889-897.
27. Rossmeisl M., Flachs P., Brauner P., Sponarova J., Matejkova O., Prazak T., et al. Role of energy charge and AMP-activated protein kinase in adipocytes in the control of body fat stores. Int J Obes Relat Metab Disord 2004, 28(Suppl 4):S38-S44.
28. Usui I., Haruta T., Iwata M., Takano A., Uno T., Kawahara J., et al. Retinoblastoma protein phosphorylation via PI 3-kinase and mTOR pathway regulates adipocyte differentiation. Biochem Biophys Res Commun 2000, 275:115-120.
29. Abella A., Dubus P., Malumbres M., Rane S.G., Kiyokawa H., Sicard A., et al. Cdk4 promotes adipogenesis through PPARgamma activation. Cell Metab 2005, 2:239-249.
30. Gaidhu M.P., Anthony N.M., Patel P., Hawke T.J., Ceddia R.B. Dysregulation of lipolysis and lipid metabolism in visceral and subcutaneous adipocytes by high-fat diet: role of ATGL, HSL, and AMPK. Am J Physiol Cell Physiol 2010, 298:C961-971.
31. Sadie-Van Gijsen H., Crowther N.J., Hough F.S., Ferris W.F. Depot-specific differences in the insulin response of adipose-derived stromal cells. Mol Cell Endocrinol 2010, 328:22-27.
32. Ibrahim M.M. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev 2010, 11:11-18.
33. Son H.J., Lee S.H., Choi S.Y. Human lactoferrin controls the level of retinoblastoma protein and its activity. Biochem Cell Biol 2006, 84:345-350.
34. Yagi M., Suzuki N., Takayama T., Arisue M., Kodama T., Yoda Y., et al. Effects of lactoferrin on the differentiation of pluripotent mesenchymal cells. Cell Biol Int 2009, 33:283-289.
35. Yagi M., Suzuki N., Takayama T., Arisue M., Kodama T., Yoda Y., et al. Lactoferrin suppress the adipogenic differentiation of MC3T3-G2/PA6 cells. J Oral Sci 2008, 50:419-425.
36. Tomlinson J.J., Boudreau A., Wu D., Abdou Salem H., Carrigan A., Gagnon A., et al. Insulin sensitization of human preadipocytes through glucocorticoid hormone induction of forkhead transcriptions factors. Mol Endocrinol 2010, 24:104-113.
37. Wellen K.E., Fucho R., Gregor M.F., Furuhashi M., Morgan C., Lindstad T., et al. Coordinated regulation of nutrient and inflammatory responses by STAMP2 is essential for metabolic homeostasis. Cell 2007, 129:537-548.
38. Chen X., Zhu C., Ji C., Zhao Y., Zhang C., Chen F., et al. STEAP4, a gene associated with insulin sensitivity, is regulated by several adipokines in human adipocytes. Int J Mol Med 2010, 25:361-367.